Paul Edick
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Paul Edick
Paul Edick was last confirmed as Board Member at Milestone Pharmaceuticals Inc. (MIST) in a filing dated May 5, 2020. Vistagen Therapeutics, Inc. reported in an 8-K filed February 20, 2026 that Paul Edick resigned as Board of Directors, effective February 13, 2026.
“On February 13, 2026, Paul Edick resigned from the Board of Directors (the "Board") of Vistagen Therapeutics, Inc. (the "Company").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2019-01-01–2020-05-05
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.